Schedule 13G ownership disclosure

TETRALOGIC PHARMACEUTICALS COR

Security class unavailable · CUSIP: 88165U109

Event date: 2019-02-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-19-001287
Form type
SC 13G/A
Filer
Robins David C.
CIK
CIK 1701122
Filed
Feb 15, 2019
Reporting period
Feb 15, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub